George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It is of course all personal opinion which makes a chat board worthwhile. Firstly next week is not an AGM that’s in Summer. Secondly I am a percentage holder, least I was 😂 so after 14 years am very much looking at the bigger picture. I believe Alastair to be a man of genuine integrity and can only praise the tech he has acquired for Avacta. But and it is a very large BUT commercialism has not followed on any front. We were promised commercial turning points in 2015 / 2016/ 2017 with various diagnostics, then Affimers, then TMAC, then Covid LFD now pre|CISION. I think in deference to Alastair and his character long term shareholders have given him every latitude. The last few months have, as they say, been just been the final straw that broke the camels back.
As to senior staff rotation / loss. It is often not a good thing but if you think about it that’s exactly what we’ve had under Alastair’s tenure. The CFO is one of the only one’s to survive and I certainly have a view on that.
Discussion boards are for discussion and exchange of knowledge. I hope this thread promotes discussion of different points of view. Sensible views are all valid.
Haha rose tinted glasses you require spec savers you are so short sighted it is unbelievable. At the end of the day all that matters is funding and FDA approval. The science strongly suggests we will get FDA approval. On FDA approval even if we did another 50% Dilution the company would still be valued in the Billions based on validation of drug and platform. Approved Oncology drugs are worth some serious cash who would have thought. Not rose tinted glasses just good old logical conclusions if the trial is successful which the data suggests it will be.
Sadly not. Think we’ll have to wait for that. Although it does raise an interesting question. If AS is no longer CEO, will the focus change from asset retention towards licensing and or TO?
Are you for real or are those rose tinted glasses welded to your face ? I suppose you’d be happy if he made that statement again then did a raise at 25p.
Well we don’t??? We are fully funded for the next 2 years.
Did they also mention the 10Bn takeover or is that the week after next?
Have you forgotten “funding - you don’t need to worry about that” - a statement that has proved to be very foolish indeed.
The results have been exceptional throughout the trial but that still hasn’t stopped the decimation of the SP - who needs to shoulder the blame for that ? You can’t ignore the fact that major errors in judgment have been made and that can’t be ignored.
That is what they said. They seem to have a good source (been right a few times although didn’t seem to know about the placing, at least they wouldn’t admit it to me) but I’m getting it third hand from someone who is leveraged on a long. Always the possibility of some shenanigans. The Fiona point seemed oddest to me. Could well mean CC .
Could explain the rise, or be a complete load of horse doo da. I’m told we’ll know by close of Tuesday. Don’t put down the pitchforks just yet as they didn’t mention the cfo getting changed and he’s the idiot I’d like to see given the Spanish Archer.
As long as the results continue to be exceptional we won’t have any issues with future funding. Sheppy go back to your yacht and fantasy lifestyle, or get that premium sorted. 👋😉
What forever? You muppet
We are fully funded you muppet.
Thankfully it’s clinicians that administer AvA6000 not CFOs
another perhaps more serious risk factor is running out of money which if deadlines are continually unmet will happen.
the rns figure **** up was unforgivable! if they can’t get that right can you imagine waiting for a dose of ava6000 and thinking i hope they get the measurement right! frighteningly true.
Yes one of the more dubious calls being spending more money on acquisitions to add to the diagnostic side when the clear value driver seemed to already be proven through AVA6000!
Why would you change when the clinical progress is so exceptional. Let it see how it plays out first. If successful then the share price will follow. New management team not going to change the fact we had a shock placing and that’s what the people on social media are actually p155ed of about. We will see at the AGM though. 👍
Don’t necessarily need to lose someone like AS but maybe a restructure is what’s called for. There’s no denying he’s made some very dubious calls as CEO but a a scientist he’s hard to fault.
A think a new, experienced CEO is essential.
Read the risk factors in last year’s results RNS losing key personnel is one of the top risks. I would say the management team are key personnel, plus we are in the middle of the end game now and I think the institutional investors were delighted to pick up shares so they won’t want additional risk either.
What make you sure that there will be no management changes Ice ?
Management change haha please. You need to look at the bigger picture. Loads of companies have failed to raise money in this challenging environment, one pharmaceutical company even decided to go else where. Deals now while preferable to shore up short term share price volatility only matter to the traders. LTH’s know deals done with more data available will be more lucrative. Don’t think there will be any changes tbh. It’s a storm in a social media tea cup. The vast majority of big holders over 200k plus shares will be looking at the longterm picture and will vote accordingly imo.
My personal belief is that a considerable number of ‘commercial’ errors of judgement have been made over the last few years. The board and particularly the chairman have a duty of care to ensure on our behalf that the company is well run. If mistakes are made by the ceo then the board shares the responsibility. It has always been a major red flag tome that the board members have never seen fit to support the company with reasonable share purchases. If they do not believe in the company why should investors new and old?
I was under the impression that FM had moved on. Is your sauce suggesting the a return of the Mc?
SoleBoy and WeAreGroot - very interesting posts. I do feel changes are needed and the totally incompetent RNS on Friday was a blunder of monumental proportions. Most of us would have triple checked that before releasing.
The share price seems to have turned a corner and a possible avalanche of news next week could propel us rapidly upwards. Fingers crossed!
Hi Touk, I have never got involved with vintage guitars so don't really have any idea.
(I have some vintage guitars of my own only because there are 40 years old from new!)
Meant to be a good source of investment these days apparently. But how you value them seems like most art, pretty arbitrary .
Soleboy explain how the board is culpable ???